“…These transfusions are repeatedly discussed as risk factors for complications like necrotizing enterocolitis, intraventricular haemorrhage, retinopathy of prematurity, thrombotic events and sepsis . In preclinical studies, PHDi are currently investigated for their beneficial potential in diverse animal models of ischaemia, for example, preconditioning against ischaemia‐reperfusion injury in kidney, heart, brain, muscle and liver . This preconditioning effect of PHDis might be extremely useful for the quality of donor organs prior to transplantation.…”